[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_2137 

# __Improve surveillance for drug resistance, invest in vaccine development infrastructure__

## Risks possibly mitigated by this Mitigation

* [Lack of effective pharmaceutical response](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1602.md)

## Closest similar item

* [Develop vaccines and promote vaccination programs](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2759.md)
* [Improve vaccine efficacy through research and development.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2512.md)
* [Investment in research and development for vaccines and agent-specific drugs.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2069.md)
* [Strengthen healthcare infrastructure, implement strict quarantine measures, develop vaccines](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1948.md)
* [Ensuring global coverage of vaccination](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_726.md)
* [Vaccine development](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_598.md)
* [Support ongoing research for vaccine development and antiviral medications, repurpose existing drugs for treatment](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2457.md)
* [Vaccines development](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_984.md)
* [Support research and development of vaccine and antiviral treatments, promote preventive measures](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2316.md)
* [Develop and distribute effective medications and vaccines.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2016.md)

